Review

Symptoms, transmission, pathogenesis, and future ways to control the spread of Coronavirus COVID-19

Volume: 5 Number: 1 July 15, 2020
  • Muhammad Ateeq
  • Ahmad Ali Qurashi Alfarooqi
  • Akhtar Muhammad *
Journal of Ongoing Chemical Research Cover
Journal of Ongoing Chemical Research
PDF Download

Symptoms, transmission, pathogenesis, and future ways to control the spread of Coronavirus COVID-19

Abstract

The infection of coronavirus (COVID-19) is caused by SARS-COV2 that is a connective agent of a hypothetically lethal ailment. It is based on the huge number of infested personages presented to the marine animal market in Wuhan City, China. There is a speculation that this may be the zoonotic origin of COVID-19. Greater efforts have been made to reduce the spread of COVID-19 from person to person to control current practice. Particular care and efforts to prevent transmission of infection should be used in common settings including children, health care providers, and interested persons. In this review, we present the symptoms, transmission, pathogenesis, and future ways to control the spread of this deadly disease.

Keywords

References

  1. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 2020; published online Jan 30. DOI:10.1001/jama.2020.1097.
  2. Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58: 686–89.
  3. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; published online Jan 29. DOI: 10.1056/NEJMoa2001316.
  4. Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus, (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents, 105924.
  5. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. https://wwwwhoint/docs/defaultsource/coronaviruse/clinica l-management-of-novel-covpdf?sfvrsn=bc7da517_2 Published on January 12, 2020.
  6. National Health Commission of the People’s Republic of China. Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 3). http://wwwnhcgovcn/yzygj/s7653p/202001/f492c9153ea94 37bb587ce2ffcbee1fa/files/39e7578d8596 4dbe81117736dd789d8fpdf Published on January 22, 2020.
  7. National Health Commission of the People’s Republic of China. Technical guideline for the laboratory test of pneumonia caused by a novel coronavirus (Second Edition).
  8. Shapiro M, London B, Nigri D, Shoss A, Zilber E, Fogel I. Middle East respiratory syndrome coronavirus: Review of the current situation in the world. Disaster Mil Med 2016; 2:9.

Details

Primary Language

English

Subjects

Organic Chemistry

Journal Section

Review

Authors

Muhammad Ateeq This is me
Pakistan

Ahmad Ali Qurashi Alfarooqi This is me
Pakistan

Akhtar Muhammad * This is me
Pakistan

Publication Date

July 15, 2020

Submission Date

September 15, 2020

Acceptance Date

-

Published in Issue

Year 2020 Volume: 5 Number: 1

IZ

https://izlik.org/JA32RD73NR